SCHEMBL21889134

SCHEMBL21889134

C=CC(=O)OCCOc1ccc(-c2ccc(C(=O)c3ccc(-c4ccc(OCCOC(=O)C=C)cc4)cc3)cc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.65
GAA P10253 1/20 0.50
ALDH1A1 P00352 3/20 0.44
TP53 P04637 2/20 0.44
TSHR P16473 2/20 0.44
HIF1A Q16665 2/20 0.44
HSD17B10 Q99714 1/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
RARB P10826 4/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 3/20 0.43
PPARA Q07869 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
PKM P14618 1/20 0.42
LSS P48449 3/20 0.42
PSMB1 P20618 1/20 0.42
PSMB5 P28074 1/20 0.42
PSMB2 P49721 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13811597 0.95 THRB (0.71) THRBGAAALDH1A1TP53TSHR
SCHEMBL11994239 0.94 THRB (0.71) THRBGAAALDH1A1L3MBTL1LMNA
SCHEMBL9418508 0.92 THRB (0.75) THRBALDH1A1TP53TSHRHIF1A
SCHEMBL899301 0.90 THRB (0.77) THRBGAAALDH1A1L3MBTL1LMNA
SCHEMBL8427321 0.90 THRB (0.68) THRBALDH1A1TP53TSHRHSD17B10
SCHEMBL2401407 0.88 THRB (0.61) THRBGAAALDH1A1TP53L3MBTL1
SCHEMBL2404494 0.88 THRB (0.61) THRBGAAALDH1A1TP53TSHR
SCHEMBL8427313 0.88 THRB (0.61) THRBGAAALDH1A1TP53TSHR
SCHEMBL24804854 0.88 THRB (0.69) THRBALDH1A1TP53TSHRHIF1A
SCHEMBL17716764 0.88 THRB (0.69) THRBALDH1A1TP53TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10954183-B2 Curable composition, semi-cured product, cured product, optical member, lens, and compound FUJIFILM CORPORATION (JP) 2021-03-23 US disclosed
US-20200115316-A1 CURABLE COMPOSITION, SEMI-CURED PRODUCT, CURED PRODUCT, OPTICAL MEMBER, LENS, AND COMPOUND FUJIFILM CORPORATION (JP) 2020-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115316-A1 CURABLE COMPOSITION, SEMI-CURED PRODUCT, CURED PRODUCT, OPTICAL MEMBER, LENS, AND COMPOUND CRYAA, Q6ZSR9, CRYZ THRB 1783/4885GAA 3348/4885ALDH1A1 735/4885
US-10954183-B2 Curable composition, semi-cured product, cured product, optical member, lens, and compound CRYAA, Q6ZSR9, CRYZ THRB 1783/4885GAA 3348/4885ALDH1A1 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.